Use Options For a Chance To Buy FOLD at a 51% Discount

Looking back to 72 days ago, Amicus Therapeutics Inc (FOLD) priced a 13,850,000 share secondary stock offering at $6.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Thursday, the stock is now 17.2% higher than the offering price..